These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 26701615)

  • 1. Increased fucosylation has a pivotal role in multidrug resistance of breast cancer cells through miR-224-3p targeting FUT4.
    Feng X; Zhao L; Gao S; Song X; Dong W; Zhao Y; Zhou H; Cheng L; Miao X; Jia L
    Gene; 2016 Mar; 578(2):232-41. PubMed ID: 26701615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-493-5p attenuates the invasiveness and tumorigenicity in human breast cancer by targeting FUT4.
    Zhao L; Feng X; Song X; Zhou H; Zhao Y; Cheng L; Jia L
    Oncol Rep; 2016 Aug; 36(2):1007-15. PubMed ID: 27375041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miRNA expression patterns in chemoresistant breast cancer tissues.
    Lv J; Xia K; Xu P; Sun E; Ma J; Gao S; Zhou Q; Zhang M; Wang F; Chen F; Zhou P; Fu Z; Xie H
    Biomed Pharmacother; 2014 Oct; 68(8):935-42. PubMed ID: 25451164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.
    Hu Y; Xu K; Yagüe E
    Breast Cancer Res Treat; 2015 Jun; 151(2):269-80. PubMed ID: 25900794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2).
    Jiao X; Zhao L; Ma M; Bai X; He M; Yan Y; Wang Y; Chen Q; Zhao X; Zhou M; Cui Z; Zheng Z; Wang E; Wei M
    Breast Cancer Res Treat; 2013 Jun; 139(3):717-30. PubMed ID: 23780685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-129-3p promotes docetaxel resistance of breast cancer cells via CP110 inhibition.
    Zhang Y; Wang Y; Wei Y; Li M; Yu S; Ye M; Zhang H; Chen S; Liu W; Zhang J
    Sci Rep; 2015 Oct; 5():15424. PubMed ID: 26487539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer.
    Hu Y; Qiu Y; Yagüe E; Ji W; Liu J; Zhang J
    Cell Death Dis; 2016 Jun; 7(6):e2291. PubMed ID: 27362808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-29b/Sp1/FUT4 axis modulates the malignancy of leukemia stem cells by regulating fucosylation via Wnt/β-catenin pathway in acute myeloid leukemia.
    Liu B; Ma H; Liu Q; Xiao Y; Pan S; Zhou H; Jia L
    J Exp Clin Cancer Res; 2019 May; 38(1):200. PubMed ID: 31097000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of ultrasound exposure on P-glycoprotein-mediated multidrug resistance in vitro and in vivo.
    Huang C; Huang S; Li H; Li X; Li B; Zhong L; Wang J; Zou M; He X; Zheng H; Si X; Liao W; Liao Y; Yang L; Bin J
    J Exp Clin Cancer Res; 2018 Sep; 37(1):232. PubMed ID: 30231924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of microRNA-27b-3p enhances tamoxifen resistance in breast cancer by increasing NR5A2 and CREB1 expression.
    Zhu J; Zou Z; Nie P; Kou X; Wu B; Wang S; Song Z; He J
    Cell Death Dis; 2016 Nov; 7(11):e2454. PubMed ID: 27809310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-Targeting of miR-124-3p and ABCC4 Promotes Sensitivity to Adriamycin in Breast Cancer Cells.
    Hu D; Li M; Su J; Miao K; Qiu X
    Genet Test Mol Biomarkers; 2019 Mar; 23(3):156-165. PubMed ID: 30807260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic analysis of gene expression pattern in has-miR-760 overexpressed resistance of the MCF-7 human breast cancer cell to doxorubicin.
    Lv J; Fu Z; Shi M; Xia K; Ji C; Xu P; Lv M; Pan B; Dai L; Xie H
    Biomed Pharmacother; 2015 Feb; 69():162-9. PubMed ID: 25661353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of miR-195 increases the sensitivity of breast cancer cells to Adriamycin treatment through inhibition of Raf-1.
    Yang G; Wu D; Zhu J; Jiang O; Shi Q; Tian J; Weng Y
    Oncol Rep; 2013 Aug; 30(2):877-89. PubMed ID: 23760062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-145 sensitizes breast cancer to doxorubicin by targeting multidrug resistance-associated protein-1.
    Gao M; Miao L; Liu M; Li C; Yu C; Yan H; Yin Y; Wang Y; Qi X; Ren J
    Oncotarget; 2016 Sep; 7(37):59714-59726. PubMed ID: 27487127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HSF1 and Sp1 regulate FUT4 gene expression and cell proliferation in breast cancer cells.
    Yang X; Wang J; Liu S; Yan Q
    J Cell Biochem; 2014 Jan; 115(1):168-78. PubMed ID: 23959823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of microRNA-141-3p in 5-fluorouracil and oxaliplatin chemo-resistance in esophageal cancer cells via regulation of PTEN.
    Jin YY; Chen QJ; Xu K; Ren HT; Bao X; Ma YN; Wei Y; Ma HB
    Mol Cell Biochem; 2016 Nov; 422(1-2):161-170. PubMed ID: 27644195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-199a-3p enhances breast cancer cell sensitivity to cisplatin by downregulating TFAM (TFAM).
    Fan X; Zhou S; Zheng M; Deng X; Yi Y; Huang T
    Biomed Pharmacother; 2017 Apr; 88():507-514. PubMed ID: 28126676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-487a resensitizes mitoxantrone (MX)-resistant breast cancer cells (MCF-7/MX) to MX by targeting breast cancer resistance protein (BCRP/ABCG2).
    Ma MT; He M; Wang Y; Jiao XY; Zhao L; Bai XF; Yu ZJ; Wu HZ; Sun ML; Song ZG; Wei MJ
    Cancer Lett; 2013 Oct; 339(1):107-15. PubMed ID: 23879965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miRNA-34a is associated with docetaxel resistance in human breast cancer cells.
    Kastl L; Brown I; Schofield AC
    Breast Cancer Res Treat; 2012 Jan; 131(2):445-54. PubMed ID: 21399894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP.
    Zhu W; Xu H; Zhu D; Zhi H; Wang T; Wang J; Jiang B; Shu Y; Liu P
    Cancer Chemother Pharmacol; 2012 Mar; 69(3):723-31. PubMed ID: 21993663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.